Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | NPC1 | O15118 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 3/20 | 0.63 |
| ▸ | PARP1 | P09874 | 1/20 | 0.62 |
| ▸ | OGG1 | O15527 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | AOC2 | O75106 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77384 | 0.85 | ALDH1A1 (0.76) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL17236166 | 0.83 | SMN1; SMN2 (0.77) | L3MBTL1ALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL17336774 | 0.83 | KDM4E (0.64) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL31305679 | 0.83 | KDM4E (0.64) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL18377765 | 0.83 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL17200636 | 0.82 | NPC1 (0.60) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL7377549 | 0.82 | PARP1 (0.55) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL1904111 | 0.81 | ALDH1A1 (0.70) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL5426936 | 0.81 | L3MBTL1 (0.75) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 | |
| SCHEMBL30618513 | 0.81 | L3MBTL1 (0.75) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | claimed |
| US-20210005900-A1 | METHOD OF GENERATING ENERGY FROM A HYDRAZIDE CONTAINING ANODE FUEL, AND FUEL CELL | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-01-07 | — | — | US | claimed |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | claimed |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-13 | — | — | US | claimed |
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2002102301-A2 | SUBSTITUTED INDOLE-2-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2002-12-27 | — | — | WO | claimed |
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2002-09-12 | — | — | US | claimed |
| CN-86105682-A | Novel benzamides, process for their preparation and their use in therapy | — | 1987-02-04 | — | — | CN | claimed |
| US-12509544-B2 | Aqueous binder formulation | BASF SE (DE) | 2025-12-30 | — | — | US | disclosed |
| EP-4130195-B1 | COMPOSITION AND LIGHT-EMITTING ELEMENT CONTAINING SAME | SUMITOMO CHEMICAL CO (JP) | 2025-09-03 | — | — | EP | disclosed |
| CN-116113635-B | Spiro compounds as melanocortin 4 receptor antagonists and uses thereof | 辉瑞公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20250084084-A1 | Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one | PFIZER INC. (US) | 2025-03-13 | — | — | US | disclosed |
| EP-4144792-B1 | PARTICULATE WATER-ABSORBENT RESIN COMPOSITION, ABSORBENT BODY AND ABSORBENT ARTICLE | SUMITOMO SEIKA CHEMICALS (JP) | 2025-01-08 | — | — | EP | disclosed |
| EP-4144803-B1 | WATER ABSORBENT RESIN COMPOSITION, ABSORBENT, AND ABSORBENT ARTICLE | SUMITOMO SEIKA CHEMICALS (JP) | 2024-12-25 | — | — | EP | disclosed |
| CN-1021441-C | PROCESS FOR PREPARATION OF NEW BENZAMIDES | ILE DE FRANCE (FR) | 1993-06-30 | — | — | CN | disclosed |
| US-5120347-A | Pre and postemergence | ROHM AND HAAS COMPANY (US) | 1992-06-09 | — | — | US | disclosed |
| WO-1989006125-A1 | 4-ARALKYL-5-SUBSTITUTED-1,2,4-TRIAZOLE-5-THIOLS | SMITHKLINE BECKMAN CORPORATION (US) | 1989-07-13 | — | — | WO | disclosed |
| EP-0323737-A1 | 4-Aralkyl-5-substituted-1,2,4-triazole-5-thiols | SMITHKLINE BEECHAM CORPORATION (US) | 1989-07-12 | — | — | EP | disclosed |
| EP-0323590-A2 | Carbazoyl derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1989-07-12 | — | — | EP | disclosed |
| CN-86105682-A | Novel benzamides, process for their preparation and their use in therapy | — | 1987-02-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084084-A1 | Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one | CSPP1, PRNP, RPLP2 | L3MBTL1 3093/4885ALDH1A1 305/4885KDM4E 1908/4885 |
| US-20020128292-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | BAD, API5, CASP2 | L3MBTL1 1507/4885ALDH1A1 144/4885KDM4E 2887/4885 |
| US-20030105140-A1 | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | BAD, API5, CASP2 | L3MBTL1 1507/4885ALDH1A1 144/4885KDM4E 2887/4885 |
| US-12509544-B2 | Aqueous binder formulation | ADH1C, AKR1C1, AKR1C2 | L3MBTL1 2558/4885ALDH1A1 70/4885KDM4E 466/4885 |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | GK, GMDS, UGCG | L3MBTL1 4699/4885ALDH1A1 87/4885KDM4E 2823/4885 |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | GK, GMDS, UGCG | L3MBTL1 4699/4885ALDH1A1 87/4885KDM4E 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.